bioRxivImmunology
Heterozygous Cell Models of STAT1 Gain-of-Function Reveal a Broad Spectrum of Interferon-Signature Gene Transcriptional Responses
O. Scott, K. Lindsay, S. Erwood, C. M. Roifman, R. D. Cohn, E. A. Ivakine
Abstract
Signal Transducer and Activator of Transcription 1 (STAT1) gain-of-function (GOF) is an autosomal dominant immune disorder marked by wide infectious predisposition, autoimmunity, vascular disease and malignancy. Its molecular hallmark, elevated phospho-STAT1 (pSTAT1) following interferon (IFN) stimulation, is seen consistently in all patients and may not fully account for the broad phenotypic spectrum associated with this disorder. While over 100 mutations have been implicated in STAT1 GOF, genotype-phenotype correlation remains limited, and current overexpression models may be of limited use in gene expression studies. We generated heterozygous mutants in diploid HAP1 cells using CRISPR/Cas9 base-editing, targeting the endogenous STAT1 gene. Our models recapitulated the molecular phenotype of elevated pSTAT1, and were used to characterize the expression of five IFN-stimulated genes under a number of conditions. At baseline, transcriptional polarization was evident among mutants compared with wild type, and this was maintained following prolonged serum starvation. This suggests a possible role for unphosphorylated STAT1 in the pathogenesis of STAT1 GOF. Following stimulation with IFN or IFN{gamma}, differential patterns of gene expression emerged among mutants, including both gain and loss of transcriptional function. This work highlights the importance of modelling heterozygous conditions, and in particular transcription factor-related disorders, in a manner which accurately reflects patient genotype and molecular signature. Furthermore, we propose a complex and multifactorial transcriptional profile associated with various STAT1 mutations, adding to global efforts in establishing STAT1 GOF genotype-phenotype correlation and enhancing our understanding of disease pathogenesis.
- organism: human
- assay: bulk RNA-seq
- research focus: cell type annotation
- research focus: differential expression
- approach: genetic perturbation / CRISPR
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Homozygous STAT2 gain-of-function mutation by loss of USP18 activity in a patient with type I interferonopathy
C. N. Gruber, M. Martin-Fernandez, … D. Bogunovic·bioRxiv·Dec 12, 2019
- STAT1 Gain-of-Function Variants Drive Altered T Cell Prevalence, Metabolism, and Heightened IL-6 Sensitivity
S. Kaviany, T. Bartkowiak, … J. C. Rathmell·bioRxiv·Nov 10, 2021
- Hyperactive STAT1 Promotes T Follicular Helper Type 1 Cell Differentiation to Trigger Autoimmunity
Ran Chen, Xuemei Chen, … Yanjun Jia·Journal of Allergy and Clinical ImmunologyPeer-reviewed·Sep 1, 2026
- Ruxolitinib partially reverses functional NK cell deficiency in patients with STAT1 gain-of-function mutations
A. Vargas Hernandez, E. M. Mace, … L. R. Forbes·bioRxiv·Jun 28, 2017
- STAT5B leukemic mutations, altering SH2 tyrosine 665, have opposing impacts on immune gene programs
Hye‐Kyung Lee, Jichun Chen, … Lothar G. Hennighausen·Life Science AlliancePeer-reviewed·Apr 14, 2025
- Altered Purinergic Signaling and CD8+ T Cell Dysregulation in STAT3 GOF Syndrome
Jose S. Campos, Montana Knight, … Sarah Emily Henrickson·JCI InsightPeer-reviewed·Sep 7, 2026